Prelude Capital Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $129K | Hold |
|
|||||
|
2024
Q1 | $131K | Hold |
|
|||||
|
2023
Q4 | $111K | Hold |
|
|||||
|
2023
Q3 | $86.1K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $110K | Hold |
|
|||||
|
2022
Q4 | $99.8K | Hold |
|
|||||
|
2022
Q3 | $153K | Hold |
|
|||||
|
2022
Q2 | $182K | Sell |
|
|||||
|
2022
Q1 | $362K | Buy |
|
|||||
|
2021
Q4 | $755K | Buy |
|
|||||
|
2021
Q3 | $77K | Buy |
|